- Author:
Hee Jung SHIN
1
;
Hak Hee KIM
;
Joo Hee CHA
Author Information
- Publication Type:Review
- Keywords: Breast; Early detection of cancer; Ultrasonography
- MeSH: Breast; Early Detection of Cancer; Female; Humans; Mass Screening; Ultrasonography; Ultrasonography, Mammary*; United States Food and Drug Administration
- From: Ultrasonography 2015;34(3):165-172
- CountryRepublic of Korea
- Language:English
- Abstract: Breast ultrasonography (US) is currently considered the first-line examination in the detection Epub ahead of print and characterization of breast lesions. However, conventional handheld US (HHUS) has several limitations such as operator dependence and the requirement of a considerable amount of radiologist time for whole-breast US. Automated breast US (ABUS), recently approved by the United States Food and Drug Administration for screening purposes, has several advantages over HHUS, such as higher reproducibility, less operator dependence, and less required physician time for image acquisition. In addition, ABUS provides both a coronal view and a relatively large field of view. Recent studies have reported that ABUS is promising in US screening for women with dense breasts and can potentially replace handheld second-look US in a preoperative setting.